Dysmenorrhea
📧 Sign up to get email alerts when something new happens for Dysmenorrhea.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-09-13FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.)
FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.) indicating a labeling modification related to celecoxib.
-
FDA approval · 2016-09-02FDA Approved: DICLOFENAC SODIUM — Original Application (SOLA Pharmaceuticals, LLC)
FDA approved SOLA Pharmaceuticals' diclofenac sodium tablet as an original generic, indicated for relief of pain and inflammation in conditi…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea [Phase 2]
Phase 2 clinical trial evaluating Viburnum opulus 3X for primary dysmenorrhea has completed. The study was sponsored by the University of Jo…
-
FDA approval · 2016-05-09FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for diclofenac sodium from Aurobindo Pharma Limited.
-
FDA approval · 2016-05-09FDA Approved: INDOMETHACIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Indomethacin, resulting in updated labeling for the product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-05-09FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen submitted by Zameer Pharmaceuticals LLC.
-
FDA approval · 2016-05-09FDA Approved: SULINDAC — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sulindac from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-03-16FDA Approved: CELECOXIB — Original Application (McKesson Corporation dba SKY Packaging)
FDA approved the original Abbreviated New Drug Application for a generic celecoxib product manufactured by McKesson Corporation dba SKY Pack…
-
FDA approval · 2016-03-15FDA Approved: ADVIL PM- DIPHENHYDRAMINE CITRATE AND IBUPROFEN TABLET, COATED — Supplemental Application (Lil Drug Store Products, Inc)
FDA approved a supplemental application for Advil PM tablets (ibuprofen and diphenhydramine citrate), expanding labeling to include this com…
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: The Effect of Kinesio Taping Application for Dysmenorrhea [NA]
An update on a clinical trial assessing the effectiveness of kinesio taping for dysmenorrhea.
-
FDA approval · 2016-02-25FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application to bring ALEVE GELCAPS (naproxen sodium) to market as a new dosage form from Bayer HealthCare LL…
-
CLINICAL_TRIALS research · 2016-02-24Clinical Trial Update: Menorrhagia, Dysmenorrhea and Iron Deficiency Among Young Women Soldiers and Effect on Activity
This clinical trial update examines menorrhagia and dysmenorrhea with iron deficiency anemia in young female soldiers and how these conditio…
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea [Phase 3]
The sponsor has withdrawn a Phase 3 trial evaluating YAZ for the treatment of Dysmenorrhea.
-
FDA approval · 2016-02-08FDA Approved: IBUPROFEN — Supplemental Application (TIME CAP LABORATORIES,INC)
FDA approved a supplemental application for ibuprofen tablets from Time Cap Laboratories, Inc.
-
FDA approval · 2016-01-21FDA Approved: MEFENAMIC ACID — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for mefenamic acid from Micro Labs Limited, granting approval for a generic product under ANDA090562…
-
FDA approval · 2015-12-23FDA Approved: CELECOXIB — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the original application for generic celecoxib by Torrent Pharmaceuticals Limited. This marks approval of a generic version of …
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Viagra in the Treatment of Primary Dysmenorrhea [Phase 1, Phase 2]
An update on Phase 1/2 studies evaluating sildenafil (Viagra) for primary dysmenorrhea, with the trial completed and results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: The Effect of Connective Tissue Massage in Women With Primary Dysmenorrhoea [NA]
A completed clinical trial evaluated the effect of connective tissue massage on primary dysmenorrhea and pelvic pain in women.
-
FDA approval · 2015-12-02FDA Approved: DICLOFENAC SODIUM — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma's original application for diclofenac sodium, granting clearance for its generic NSAID product. It is indica…
-
FDA approval · 2015-09-23FDA Approved: CELECOXIB — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Celecoxib under an Original Application for generic Celecoxib. The approval covers multiple indications common…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea [Phase 3]
This document reports the completion of a Phase 3 comparative trial evaluating BAY86-5300 for dysmenorrhea. The study compared BAY86-5300 wi…
-
FDA approval · 2015-08-24FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen by Hikma Pharmaceuticals USA Inc., indicating changes to the product's approval.
-
FDA approval · 2015-08-21FDA Approved: CELECOXIB — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for a generic Celecoxib product. This marks the entry of a generic celecoxib into…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Effectiveness of Additional Self-care Acupressure for Women With Menstrual Pain Compared to Usual Care Alone [NA]
A completed clinical trial evaluating whether adding self-care acupressure improves outcomes for dysmenorrhea (menstrual pain) compared with…
-
FDA approval · 2015-06-09FDA Approved: CELECOXIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' Original Application for celecoxib, enabling a generic version of Celecoxib to enter the market.